About Mathieu Spriet
Form D filings for Veterinary Molecular Imaging in 2024 list Mathieu Spriet as director.
Mathieu Spriet first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Mathieu Spriet in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mathieu Spriet works with at each company, as listed on that company's latest Form D.
Veterinary Molecular Imaging, Inc. · Form D, Jan 24, 2024
DB
David Beylin
Executive officer and director
MC
Mark Casner
President and CEO, director